Logo

Abbott Extends Tender Offer for Alere Preferred Stock

Oct 02, 2017 | staff reporter

NEW YORK (GenomeWeb) – Abbott today extended its tender offer to purchase all outstanding shares of Alere's Series B convertible perpetual preferred stock at $402 per share.

The offer has been extended to 11:59 p.m. EST, Oct. 3. It was previously scheduled to expire at 11:59 p.m. EST, Sept. 29, and is being extended to allow additional time for the completion of Abbott's planned $5.3 billion buy of Alere, anticipated to be completed on Oct. 3. Regulators last week cleared the way for the deal. 

Filed under

Business News
Molecular Diagnostics
mergers & acquisitions
tender offer
Abbott
Breaking News
The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.